Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Redmond

Showing results (171-180 of 205) with videos related to

Pageof 21
Sort By:
Oncotarget|August 7, 2019
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal cryptLouise R Dutton, Owen P Hoare, Amy M B McCorry, et al.
Oncotarget|July 19, 2016
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancerJulie N Graff, Joshi J Alumkal, Charles G Drake, et al.
Breast Cancer Research : BCR|January 8, 2021
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerKatherine Sanchez, Isaac Kim, Brie Chun, et al.
Journal for Immunotherapy of Cancer|May 22, 2025
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clusteringNisha Holay, Rashi Yadav, Sae Jeong Ahn, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 2023
Computed cardiopulmonography and the idealized lung clearance index, iLCI<sub>2.5</sub>, in early-stage cystic fibrosisDominic Sandhu, Jennifer L Redmond, Nicholas M J Smith, et al.
Chest|February 12, 2024
Computed Cardiopulmonography for the Detection of Early Smoking-Related Changes in the Lungs of Young Individuals Who SmokeJennifer L Redmond, Fiona Kendall, Nicholas M J Smith, et al.
Molecular Cancer Research : MCR|March 18, 2022
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor ImmunityMia Han, Bianca Nguyen, Jack Y Lee, et al.
Cell Reports|June 17, 2014
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancerSandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Science Translational Medicine|April 9, 2025
The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogrammingAnnah S Rolig, Xiyu Peng, Elizabeth R Sturgill, et al.
Pageof 21

Showing results (171-180 of 205) with videos related to

Sort By:
Pageof 21
Oncotarget|August 7, 2019
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal cryptLouise R Dutton, Owen P Hoare, Amy M B McCorry, et al.
Oncotarget|July 19, 2016
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancerJulie N Graff, Joshi J Alumkal, Charles G Drake, et al.
Breast Cancer Research : BCR|January 8, 2021
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerKatherine Sanchez, Isaac Kim, Brie Chun, et al.
Journal for Immunotherapy of Cancer|May 22, 2025
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clusteringNisha Holay, Rashi Yadav, Sae Jeong Ahn, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 2023
Computed cardiopulmonography and the idealized lung clearance index, iLCI<sub>2.5</sub>, in early-stage cystic fibrosisDominic Sandhu, Jennifer L Redmond, Nicholas M J Smith, et al.
Chest|February 12, 2024
Computed Cardiopulmonography for the Detection of Early Smoking-Related Changes in the Lungs of Young Individuals Who SmokeJennifer L Redmond, Fiona Kendall, Nicholas M J Smith, et al.
Molecular Cancer Research : MCR|March 18, 2022
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor ImmunityMia Han, Bianca Nguyen, Jack Y Lee, et al.
Cell Reports|June 17, 2014
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancerSandra Van Schaeybroeck, Murugan Kalimutho, Philip D Dunne, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Science Translational Medicine|April 9, 2025
The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogrammingAnnah S Rolig, Xiyu Peng, Elizabeth R Sturgill, et al.
Pageof 21